NLX-266 is a selective 5-HT1A receptor agonist that exhibits biased signaling towards ERK1/2 pathways. This compound demonstrates significant potential in research related to neurodegenerative diseases, particularly Parkinson's disease. Its unique mechanism may facilitate the investigation of receptor-mediated pathways and their implications in disease progression.
NLX-266 is a selective 5-HT1A receptor agonist that exhibits biased signaling towards ERK1/2 pathways. This compound demonstrates significant potential in research related to neurodegenerative diseases, particularly Parkinson's disease. Its unique mechanism may facilitate the investigation of receptor-mediated pathways and their implications in disease progression.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
